openPR Logo
Press release

Asia Pacific Platelet Rich Plasma Market is Projected to Reach US$ 110.0 Million by the end of 2023

11-23-2017 08:35 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Asia Pacific Platelet Rich Plasma Market is Projected to Reach

The market for platelet rich plasma in Asia Pacific features a semi-consolidated competitive landscape. A new study by Transparency Market Research (TMR) indicates that players such as Arthrex Inc., Harvest Technologies, DePuy Synthes, Zimmer-Biomet, and Stryker have a strong foothold in the market owing to their strong expertise and extensive research and development efforts. By the end of 2023, the overall value of the Asia Pacific platelet rich plasma (PRP) market is estimated to rise to US$110.0 mn. The market will expand at a noteworthy 15.4% CAGR from 2015 to 2023.

Read Report Overview @ https://www.transparencymarketresearch.com/asia-pacific-platelet-rich-plasma-market.html

Based on application, the orthopedic surgeries segment will continue to dominate the market until 2023. The widening base of geriatrics is one of the primary factors fuelling the growth of the segment. The demand for PRP in cosmetic surgeries is also anticipated to increase at a brisk pace during the review period. In terms of country, China will continue to account for the lion’s share in the region until 2023. The growth of the country can be attributed to the high awareness and growing investments in research and development activities in the field of PRP. Owing to these factors, the country will rise at a remarkable CAGR of 17.0% during the same period.

The continual research and development activities have led to the introduction of several advanced and innovative PRP devices, which in turn has provided a fillip to the Asia Pacific PRP market. Over the past few years, Asia Pacific has witnessed a boom in the medical tourism sector. Advancements in healthcare in the region have rendered it as a major destination for cosmetic surgeries at affordable costs for people from all across the world. “With millions of people opting for cosmetic surgeries, especially non-invasive type, the demand for PRP in APAC is expected to follow a notable growth trajectory,” says TMR’s lead analyst.

Besides this, the growing incidence of sports injuries, orthopedic diseases, obesity, neurological disorders, and cardiovascular diseases is stoking the growth of the market. The increasing awareness regarding PRP devices across developing countries is also playing a vital role in the development of the Asia Pacific platelet rich plasma market.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8707

“In recent type, cosmetic surgeries have picked up momentum as a commercialized procedure rather than a treatment for certain skin issues,” says a TMR analyst. The commercialization of these surgeries has triggered the prices of PRP therapies. This, in turn, is acting as a stumbling block in the growth of the Asia Pacific platelet rich plasma market. Moreover, the rising awareness pertaining to the threats associated with the use of PRP is limiting its widespread adoption across the region. Nevertheless, with the introduction of new applications of PRP technologies, the market is expected to tread along a healthy growth track in the near future.

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific Platelet Rich Plasma Market is Projected to Reach US$ 110.0 Million by the end of 2023 here

News-ID: 829804 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for PRP

Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Global Platelet Rich Plasma (PRP) Industry
Global Platelet Rich Plasma (PRP) Industry Global PRP market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Harvest Technologies DePuy Synthes Stryker Zimmer Biomet Arthrex Exactech Emcyte Corporation Arteriocyte Adilyfe Try Sample Report @ https://www.wiseguyreports.com/sample-request/1140003-global-prp-market-research-report-2017 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of PRP in
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.
Competitive Landscape for PRP Market Key Trends 2024
Global Platelet Rich Plasma (PRP) Market: Snapshot Of late, the global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market. In addition to this, the surge in cosmetic